← Encompass Health Corp EHC
Market Price
$123.49
Market Cap
$12.25B
P/E Ratio
22.29
Revenue (FY 2025)
↑10.5% YoY
$5.94B
3-Yr CAGR: 10.9%
Net Income
↑24.2% YoY
$566.20M
Net Margin: 9.5%
Free Cash Flow
↑21.9% YoY
$439.20M
FCF Yield: 3.59%
EPS (Diluted)
↑24.2% YoY
$5.54
Basic: $5.62
Return on Equity
Efficiency
23.2%
ROA: 8.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (EHC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $3,646.0M | — | $3,473.9M | $247.6M | — | $2.59 | — | $634.4M | $456.7M | — |
| FY 2017 | $3,919.0M | +7.5% | $3,764.6M | $256.3M | +3.5% | $2.69 | +3.9% | $657.2M | $431.4M | -5.5% |
| FY 2018 | $4,277.3M | +9.1% | $4,130.0M | $292.3M | +14.0% | $2.93 | +8.9% | $762.4M | $507.9M | +17.7% |
| FY 2019 | $4,605.0M | +7.7% | $4,445.3M | $358.7M | +22.7% | $3.61 | +23.2% | $635.3M | $262.9M | -48.2% |
| FY 2020 | $4,644.4M | +0.9% | $4,460.2M | $284.2M | -20.8% | $2.85 | -21.1% | $704.7M | $308.7M | +17.4% |
| FY 2021 | $5,121.6M | +10.3% | $4,957.0M | $412.2M | +45.0% | $4.11 | +44.2% | $715.8M | $186.9M | -39.5% |
| FY 2022 | $4,348.6M | -15.1% | $4,172.9M | $271.0M | -34.3% | $2.70 | -34.3% | $705.8M | $141.0M | -24.6% |
| FY 2023 | $4,801.2M | +10.4% | $4,657.7M | $352.0M | +29.9% | $3.47 | +28.5% | $850.8M | $267.7M | +89.9% |
| FY 2024 | $5,373.2M | +11.9% | $5,235.8M | $455.7M | +29.5% | $4.46 | +28.5% | $1,002.8M | $360.3M | +34.6% |
| FY 2025 | $5,935.2M | +10.5% | $5,812.0M | $566.2M | +24.2% | $5.54 | +24.2% | $1,175.6M | $439.2M | +21.9% |
Valuation
Market Price
$123.49
Market Cap
$12.25B
Enterprise Value
$14.62B
P/E Ratio
22.29
P/B Ratio
5.02
FCF Yield
3.59%
Dividend Yield
0.58%
Shares Outstanding
Profitability & Margins
Gross Margin
97.92%
Operating Margin
18.13%
Net Margin
9.54%
Return on Equity (ROE)
23.22%
Return on Assets (ROA)
7.99%
Asset Turnover
0.84x
Revenue 3-Yr CAGR
10.92%
Financial Health & Liquidity
Current Ratio
16.53
Cash Ratio
1.32
Debt / Equity
1.004
Debt / Assets
0.345
Cash & Equivalents
$72.20M
Total Debt
$2.45B
Book Value / Share
$24.58
Cash Flow Efficiency
Operating Cash Flow
$1.18B
Capital Expenditures (CapEx)
$736.40M
Free Cash Flow
$439.20M
OCF / Revenue
19.81%
FCF / Revenue
7.40%
FCF 3-Yr CAGR
46.04%
Per Share Metrics
EPS (Diluted)
$5.54
EPS (Basic)
$5.62
Dividends / Share
$0.72
Book Value / Share
$24.58
EPS YoY Growth
24.22%
Balance Sheet (FY 2025)
Total Assets
$7.09B
Total Liabilities
$3.81B
Stockholders' Equity
$2.44B
Current Assets
$905.90M
Current Liabilities
$54.80M